US 10548964
Antigens and vaccines directed against human enteroviruses
granted A61KA61K2039/5256A61K2039/5258
Quick answer
US patent 10548964 (Antigens and vaccines directed against human enteroviruses) held by SENTINEXT THERAPEUTICS Sdn Bhd expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SENTINEXT THERAPEUTICS Sdn Bhd
- Grant date
- Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K2039/5256, A61K2039/5258, A61K2039/70, A61K39/12